Nicolas Masurier

Montpellier, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Ring-opening simplification of thiazolyl-pyrazoline-triazole hybrids: synthesis, SAR and antifolate mechanism against Leishmania major.

Ring-opening simplification of thiazolyl-pyrazoline-triazole hybrids: synthesis, SAR and antifolate mechanism against Leishmania major.

Journal: RSC medicinal chemistry

Published: May 13, 2026

Vegetable Oil-Based Materials for Drug Delivery Systems and Wound Dressings.

Vegetable Oil-Based Materials for Drug Delivery Systems and Wound Dressings.

Journal: Macromolecular bioscience

Published: August 29, 2025

Identification of p-aminobenzylamine derivatives as dual non-covalent inhibitors of the transmembrane host proteases TMPRSS2 and HAT proteases with anti-viral potential.

Identification of p-aminobenzylamine derivatives as dual non-covalent inhibitors of the transmembrane host proteases TMPRSS2 and HAT proteases with anti-viral potential.

Journal: RSC medicinal chemistry

Published: July 31, 2025

Recent advances in patented inhibitors targeting serine proteases in inflammatory diseases.

Recent advances in patented inhibitors targeting serine proteases in inflammatory diseases.

Journal: European journal of medicinal chemistry

Published: July 25, 2025

The Thienopyrimidinone Gamhépathiopine Targets the QO Site of Plasmodium falciparum Cytochrome b.

The Thienopyrimidinone Gamhépathiopine Targets the QO Site of Plasmodium falciparum Cytochrome b.

Journal: ACS infectious diseases

Published: June 03, 2025

Amino acid-modified chalcone derivatives with in vitro and in vivo efficacy against colon cancer.

Amino acid-modified chalcone derivatives with in vitro and in vivo efficacy against colon cancer.

Journal: European journal of medicinal chemistry

Published: May 27, 2025

Novel N-Arylmethyl-aniline/chalcone hybrids as potential VEGFR inhibitors: synthesis, biological evaluations, and molecular dynamic simulations.

Novel N-Arylmethyl-aniline/chalcone hybrids as potential VEGFR inhibitors: synthesis, biological evaluations, and molecular dynamic simulations.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: November 20, 2023

Novel thienopyrimidones targeting hepatic and erythrocytic stages of Plasmodium parasites with increased microsomal stability.

Novel thienopyrimidones targeting hepatic and erythrocytic stages of Plasmodium parasites with increased microsomal stability.

Journal: European journal of medicinal chemistry

Published: July 03, 2023

Novel hydrazone-isatin derivatives as potential EGFR inhibitors: Synthesis and in vitro pharmacological profiling.

Novel hydrazone-isatin derivatives as potential EGFR inhibitors: Synthesis and in vitro pharmacological profiling.

Journal: Archiv der Pharmazie

Published: May 03, 2023

2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling.

2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling.

Journal: European journal of medicinal chemistry

Published: March 31, 2023

New antiplasmodial 4-amino-thieno[3,2-d]pyrimidines with improved intestinal permeability and microsomal stability.

New antiplasmodial 4-amino-thieno[3,2-d]pyrimidines with improved intestinal permeability and microsomal stability.

Journal: European journal of medicinal chemistry

Published: September 12, 2022

3-Substituted-2,3-Dihydrothiazole as a promising scaffold to design EGFR inhibitors.

3-Substituted-2,3-Dihydrothiazole as a promising scaffold to design EGFR inhibitors.

Journal: Bioorganic chemistry

Published: July 17, 2022

Showing 1-12 of 38

Last Updated: 09/26/2026